Rigel Pharmaceuticals RIGL Single reportable segment — Provision for income taxes
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Rigel Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:IncomeTaxExpenseBenefit.
The official record: Rigel Pharmaceuticals’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Rigel Pharmaceuticals's single reportable segment — provision for income taxes.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Rigel Pharmaceuticals's single reportable segment — provision for income taxes?
- Rigel Pharmaceuticals (RIGL) reported single reportable segment — provision for income taxes of $3M in Q1 2026.
- What does single reportable segment — provision for income taxes mean?
- Represents the estimated income tax expense or benefit recognized by the segment during the reporting period. This reflects the impact of tax regulations and deferred tax assets or liabilities on the company's bottom line.